Literature DB >> 17785692

Genetic disorders in the GH IGF-I axis in mouse and man.

M J E Walenkamp1, J M Wit.   

Abstract

Animal knockout experiments have offered the opportunity to study genes that play a role in growth and development. In the last few years, reports of patients with genetic defects in GH-IGF-I axis have greatly increased our knowledge of genetically determined causes of short stature. We will present the animal data and human reports of genetic disorders in the GH-IGF-I axis in order to describe the role of the GH-IGF-I axis in intrauterine and postnatal growth. In addition, the effects of the GH-IGF-I axis on the development and function of different organ systems such as brain, inner ear, eye, skeleton, glucose homeostasis, gonadal function, and immune system will be discussed. The number of patients with genetic defects in the GH-IGF-I axis is small, and a systematic diagnostic approach and selective genetic analysis in a patient with short stature are essential to identify more patients. Finally, the implications of a genetic defect in the GH-IGF-I axis for the patient and the therapeutic options will be discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17785692     DOI: 10.1530/EJE-07-0148

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  21 in total

1.  Gestational-neonatal iron deficiency suppresses and iron treatment reactivates IGF signaling in developing rat hippocampus.

Authors:  Phu V Tran; Stephanie J B Fretham; Jane Wobken; Bradley S Miller; Michael K Georgieff
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-11-16       Impact factor: 4.310

2.  Pregnancy-associated plasma protein (PAPP)-A expressed in the mammary gland controls epithelial cell proliferation and differentiation.

Authors:  Makoto Nakasato; Hitoshi Kohsaka; Tetsuya Mizutani; Gen Watanabe; Kazuyoshi Taya; Kentaro Nagaoka
Journal:  Endocrine       Date:  2012-08-17       Impact factor: 3.633

Review 3.  The role of liver-derived insulin-like growth factor-I.

Authors:  Claes Ohlsson; Subburaman Mohan; Klara Sjögren; Asa Tivesten; Jörgen Isgaard; Olle Isaksson; John-Olov Jansson; Johan Svensson
Journal:  Endocr Rev       Date:  2009-07-09       Impact factor: 19.871

4.  Insulin growth factor 1 receptor/PI3K/AKT survival pathway in outer segment membranes of rod photoreceptors.

Authors:  Ashok K Dilly; Raju V S Rajala
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-19       Impact factor: 4.799

5.  GH1 T1663A polymorphism and cancer risk: a meta-analysis of case-control studies.

Authors:  Jing Shi; Jian-Huan Tong; Shuang Cai
Journal:  Tumour Biol       Date:  2014-01-25

Review 6.  Expanding the mind: insulin-like growth factor I and brain development.

Authors:  A Joseph D'Ercole; Ping Ye
Journal:  Endocrinology       Date:  2008-08-07       Impact factor: 4.736

Review 7.  Skeletal effects of growth hormone and insulin-like growth factor-I therapy.

Authors:  Richard C Lindsey; Subburaman Mohan
Journal:  Mol Cell Endocrinol       Date:  2015-09-25       Impact factor: 4.102

8.  Maternal high-fat diet promotes body length increases and insulin insensitivity in second-generation mice.

Authors:  Gregory A Dunn; Tracy L Bale
Journal:  Endocrinology       Date:  2009-10-09       Impact factor: 4.736

Review 9.  Regulation of muscle mass by growth hormone and IGF-I.

Authors:  C P Velloso
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

10.  Cre-mediated recombination in pituitary somatotropes.

Authors:  Igor O Nasonkin; Mary Anne Potok; Sally A Camper
Journal:  Genesis       Date:  2009-01       Impact factor: 2.487

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.